Organizes content both by individual pathogens and by important clinical syndromes, broadening the context to clearly present relevant, complex clinical information.
Contains multiple new chapters on both SARS-CoV-2 and anti-fungal therapy, as well as new chapters on bacteriophages and related agents, infections following traumatic injuries, communication to the public about infectious diseases, and the effects of climate change on infectious diseases.
Provides up-to-date coverage of recent advances in the field: an increasing understanding of the agents, immune responses, and the growing armamentarium of diagnostics (such as nucleic acid amplification and next-generation sequencing); new treatments (such as monoclonal antibodies, new antifungals, antivirals, and phage therapy); and emerging preventive measures (such as new vaccines being developed for RSV), and our relationship with the human microbiome.
Features more than 1,500 high-quality, full-color photographs―with many new to this edition.
Shares the extensive experience of new editors Drs. Jeffrey I. Cohen and Steven M. Holland, both from Bethesda, MD, as well as a new team of expert associate editors Drs. Yohei Doi, Wendy S. Garrett, Ann R. Falsey, Eleanor Wilson, Kieren Marr, and Edward Mitre—each a leading authority in their field.
Includes perspectives from hundreds of leading experts from a truly global community, including authors from Australia, Canada, and countries in Europe, Asia, and South America.
Includes regular updates online for the life of the edition.
PART I: BASIC PRINCIPLES IN THE DIAGNOSIS AND MANAGEMENT OF INFECTIOUS DISEASES Section A: Microbial Pathogens 1. A Molecular Perspective of Microbial Pathogenicity 2. The Human Microbiome 3. Prebiotics, Probiotics, and Synbiotics
Section B: Host Defense Mechanisms 4. Innate (General or Nonspecific) Host Defense Mechanisms 5. Adaptive Immunity: Antibodies and Immunodefiencies 6. Cell-Mediated Defense Against Infection 7. Mucosal Immunity 8. Granulocytic Phagocytes 9. Complement and Deficiencies 10. Human Genetics and Infection 11. Nutrition, Immunity, and Infection 12. Evaluation of the Patient with Suspected Immunodeficiency
Section C: Epidemiology of Infectious Disease 13. Principles of Applied Epidemiology for the Practice of Infectious Diseases 14. Emerging and Reemerging Infectious Disease Threats 15. Bioterrorism: An Overview
Section D: Clinical Microbiology 16. The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation
Section E: Antiinfective Therapy 17. Principles of Anti-Infective Therapy 18. Molecular Mechanisms of Antibiotic Resistance in Bacteria 19. Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents 20. Penicillins and β-Lactamase Inhibitors 21. Cephalosporins and Cephalosporin/β-Lactamase Inhibitor Combinations 22. Carbapenems, Carbapenem/β-Lactamase Inhibitor Combinations, and Aztreonam 23. Antibiotic Allergy 24. Aminoglycosides 25. Tetracyclines, Tetracycline Derivatives, and Chloramphenicol 26. Rifamycins 27. Metronidazole 28. Macrolides and Clindamycin 29. Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin) 30. Streptogramins (Quinupristin-Dalfopristin) and Lipopeptides (Daptomycin) 31. Polymyxins (Polymyxin B and Colistin) 32. Linezolid,Tedizolid, and Other Oxazolidinones 33. Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole 34. Quinolones 35. Antibiotics in Advanced Development and Other Agents 36. Urinary Tract Agents: Nitrofurantoin, Fosfomycin and Methenamine 37. Topical Antibacterials 38. Antimycobacterial Agents 39. Bacteriophage Therapy, Endolysin Therapy and Antimicrobial Peptide Therapy 40. Antifungal Agents: Polyene Antifungals 41. Antifungal Drugs: Azole 42. Antifungal Drugs: Echinocandins and Other Beta-D-glucan Inhibitors 43. Antifungal Drugs: Flucytosine 44. Antimalarial Drugs 45. Drugs for Protozoal Infections Other Than Malaria 46. Drugs for Helminths 47. Antiviral Agents: General Principles 48. Antiviral Drugs for Influenza and Other Respiratory Virus Infections Except for SARS-CoV-2 49. Antivirals Against Herpesviruses 50. Antiviral Drugs Against Hepatitis Viruses 51. Miscellaneous Antivirals Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir) 52. Immunomodulators 53. Hyperbaric Oxygen 54. Antimicrobial Stewardship 55. Designing and Interpreting Clinical Studies in Infectious Diseases 56. Outpatient Parenteral Antimicrobial Therapy
PART II: MAJOR CLINICAL SYNDROMES Section A: Fever 57. Temperature Regulation and the Pathogenesis of Fever 58. Fever of Unknown Origin 59. The Acutely Ill Patient with Fever and Rash
Section B: Upper Respiratory Tract Infections 60. The Common Cold 61. Pharyngitis 62. Acute Laryngitis 63. Otitis Externa, Otitis Media, and Mastoiditis 64. Sinusitis 65. Epiglottitis 66. Infections of the Oral Cavity, Neck, and Head
Section F: Intraabdominal Infections 76. Peritonitis and Intraperitoneal Abscesses 77. Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis) 78. Pancreatic Infection 79. Splenic Abscess 80. Appendicitis 81. Diverticulitis and Neutropenic Enterocolitis
Section G: Cardiovascular Infections 82. Endocarditis and Intravascular Infections 83. Prosthetic Valve Endocarditis 84. Infections of Nonvalvular Cardiovascular Devices 85. Prophylaxis of Infective Endocarditis 86. Myocarditis and Pericarditis 87. Mediastinitis
Section H: Central Nervous System Infections 88. Approach to the Patient with Central Nervous System Infection 89. Acute Meningitis 90. Chronic Meningitis 91. Encephalitis 92. Brain Abscess 93. Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis 94. Cerebrospinal Fluid Shunt and Drain Infections
Section I: Skin and Soft Tissue Infections 95. Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections 96. Myositis and Myonecrosis 97. Lymphadenitis and Lymphangitis
Section J: Gastrointestinal Infections and Food Poisoning 98. Syndromes of Enteric Infection 99. Esophagitis 100. Diarrhea with Little or No Fever 101. Acute Dysentery Syndromes (Diarrhea with Fever) 102. Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers 103. Foodborne Disease (Food Poisoning) 104. Tropical Sprue and Environmental Enteric Dysfunction
Section K: Bone and Joint Infections 105. Infectious Arthritis of Native Joints 106. Osteomyelitis 107. Orthopaedic Implant-Associated Infections
Section L: Diseases of The Reproductive Organs and Sexually Transmitted Diseases 108. Anogenital Skin and Mucous Membrane Lesions 109. Urethritis 110. Vulvovaginitis and Cervicitis 111. Infections of the Female Pelvis 112. Prostatitis, Epididymitis, and orchitis
Martin J. Blaser, MD, Henry Rutgers Chair of the Human Microbiome, Professor of Medicine and Pathology & Laboratory Medicine - RWJMS; Director, Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA, Jeffrey I. Cohen, MD, Bethesda, MD and Steven M. Holland, MD, Bethesda, MD
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our
Cookie Preference Center
We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors.
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
You may also be able to exercise your privacy choices as described in our Privacy Policy
Manage Consent Preferences
Strictly Necessary Cookies
Always active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.